Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: A regulated mechanism that controls T-cell activation and function

Human Immunology

Volumn 61, Issue 1, 2000, Pages 44-50

  Mingari, Maria Cristina ^a,b   Ponte, Marco ^a,b   Vitale, Chiara ^a,b   Bellomo, Rosa ^a   Moretta, Lorenzo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Cytolytic T lymphocytes; HLA class I; Interleukin 15; Killer inhibitory receptors; NK like activity; Transforming growth factor

Indexed keywords

HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; HISTOCOMPATIBILITY; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

CYTOKINES; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033958520     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(99)00158-5     Document Type: Article

References (55)

1. Kiessling R., Klein E., Wigzell H. "Natural Killer" cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 5:1975;112.
2. Trinchieri G. Biology of natural killer cells. Adv Immunol. 47:1989;187.
3. Moretta L., Ciccone E., Mingari M.C., Biassoni R., Moretta A. Human NK cells origin, clonality, specificity and receptors . Adv Immunol. 55:1994;341.
4. Ljunggren H.G., Kärre K. In search of the "missing self". MHC molecules and NK cell recognition. Immunol Today. 11:1990;237.
5. Moretta A., Bottino C., Vitale M., Pende D., Biassoni R., Mingari M.C., Moretta L. Receptors for HLA class-I molecules in human natural killer cells. Annu Rev Immunol. 14:1996;619.
6. Moretta L., Ciccone E., Moretta A., Höglund P., Oöhlen C., Kärre K. Allorecognition by NK cells nonself or no self? Immunol Today. 13:1992;300.
7. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., Spies T. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:1999;727.
8. Sivori S., Vitale M., Morelli L., Sanseverino L., Augugliaro R., Bottino C., Moretta L., Moretta A. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J Exp Med. 186:1997;1129.
9. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med. 187:1998;2065.
10. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A. Molecular cloning of NKp46 a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity . J Exp Med. 188:1998;953.
11. Cantoni C., Bottino C., Vitale M., Pessino A., Augugliaro R., Malaspina A., Parolini S., Moretta L., Moretta A., Biassoni R. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med. 189:1999;787.
12. Valiante N.M., Lienert K., Shilling H.G., Smits B.J., Parham P. Killer cell receptor keeping pace with MHC class I evolution . Immunol Rev. 155:1997;155.
13. + NK cells by the the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J Exp Med. 172:1990;1589.
14. Moretta A., Vitale M., Bottino C., Orengo A., Morelli L., Augugliaro R., Barbaresi M., Ciccone E., Moretta L. P58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 178:1993;597.
15. Wagtmann N., Biassoni R., Cantoni C., Verdiani S., Malnati M.S., Vitale M., Bottino C., Moretta L., Moretta A., Long E.O. Molecular clones of the p58 NK cell receptor reveal immunoglobulin related molecules with diversity in both the extra- and intracellular domains. Immunity. 2:1995;439.
16. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405.
17. Litwin V., Gumperz J.E., Parham P., Phillips J.H., Lanier L.L. NKB1 a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules . J Exp Med. 180:1994;537.
18. Vitale M., Sivori S., Pende D., Augugliaro R., Di Donato C., Amoroso A., Malnati M., Bottino C., Moretta L., Moretta A. Physical and functional independency of p70 and p58 natural killer (NK) cell receptor for HLA class I their role in the definition of different groups of alloreative NK cell clones . Proc Natl Acad Sci USA. 93:1996;1453.
19. Pende D., Biassoni R., Cantoni C., Verdiani S., Falco M., Di Donato C., Accame L., Bottino C., Moretta A., Moretta L. The natural killer cell receptor specific for HLA-A allotypes a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer . J Exp Med. 184:1996;505.
20. Doring C., Scheidegger D., Samaridis J., Cella M., Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol. 156:1996;3098.
21. Yokoyama W.M., Seaman W.E. The Ly49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells the NK gene complex . Annu Rev Immunol. 11:1993;613.
22. Aramburu J., Balboa M.A., Ramirez A., Silva A., Acevedo A., Sánchez-Madrid F., de Landázuri M.O., Lòpez-Botet M. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-γ/δ+ T lymphocytes. Inhibition of IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J Immunol. 44:1990;3238.
23. Peréz-Villar J.J., Melero I., Rodríguez A., Carretero M., Aramburu J., Sivori S., Orengo A.M., Moretta A., Lòpez-Botet M. Functional ambivalence of the kp43 (CD94) NK cell-associated surface antigen. J Immunol. 154:1995;5779.
24. Moretta A., Vitale M., Sivori S., Bottino C., Morelli L., Augugliaro R., Barbaresi M., Pende D., Ciccone E., Lòpez-Botet M., Moretta L. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. J Exp Med. 180:1994;545.
25. Sivori S., Vitale M., Bottino C., Marcenaro E., Sanseverino L., Parolini S., Moretta L., Moretta A. CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies . Eur J Immunol. 26:1996;2487.
26. Carretero M., Cantoni C., Bellón T., Bottino C., Biassoni R., Rodríguez A., Pérez-Villar J.P., Moretta L., Moretta A., Lòpez-Botet M. The CD94 and NKG2-A C-type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur J Immunol. 27:1997;563.
27. Lazetic S., Chang C., Houchins J.P., Lanier L.L., Phillips J.H. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. J Immunol. 157:1996;4741.
28. Braud V.M., Allan D.S.J., O'Callaghan C.A., Sàderstràm K., D'Andrea A., Ogg G.S., Lazetic S., Young N.T., Bell J.I., Phillips J.H., Lanier L.L., McMichael A.J. HLA-E binds to natural killer receptor VD94/NKG2A, B and C. Nature. 391:1998;795.
29. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., Lòpez-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA. 95:1998;5199.
30. Samaridis J., Colonna M. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells structural evidence for new stimulatory and inhibitory pathways . Eur J Immunol. 21:1996;660.
31. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peters L., Hsu M. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity. 7:1997;273.
32. Cantoni C., Verdiani S., Falco M., Pessino A., Cilli M., Conte R., Pende D., Ponte M., Mikaelsson M.S., Moretta L., Biassoni R. p49, A putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol. 28:1998;1980.
33. Ponte M., Cantoni C., Biassoni R., Tradori-Cappai A., Bentivoglio G., Vitale C., Bertone S., Moretta A., Moretta L., Mingari M.C. Inhibitory receptors sensing HLA-G1 molecules in pregnancy decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor . Proc Natl Acad Sci USA. 96:1999;5674.
34. Ferrini S., Cambiaggi A., Meazza R., Sforzini R., Marciano S., Mingari M.C., Moretta L. T cell clones expressing the NK-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function. Eur J Immunol. 24:1994;2294.
35. Mingari M.C., Vitale C., Cambiaggi A., Schiavetti F., Melioli G., Ferrini S., Poggi A. Cytolytic T lymphocytes displaying natural killer (NK)-like activity expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production . Int Immunol. 7:1995;697.
36. Phillips J.H., Gumperz J.E., Parham P., Lanier L.L. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science. 268:1995;403.
37. Mingari M.C., Ponte M., Cantoni C., Vitale C., Schiavetti F., Bertone S., Bellomo R., Tradori-Cappai A., Biassoni R. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells . Int Immunol. 9:1997;485.
38. Mingari M.C., Schiavetti F., Ponte M., Vitale C., Maggi E., Romagnani S., Demarest J., Pantaleo G., Fauci A.S., Moretta L. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell population. Proc Natl Acad Sci USA. 93:1996;12433.
39. Olcese L., Lang P., Vély F., Cambiaggi A., Marguet D., Bléry M., Hippen K.L., Biassoni R., Moretta A., Moretta L., Cambier J.C., Vivier E. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatase. J Immunol. 156:1996;4531.
40. Burshtyn D.N., Scharenberg A.M., Wagtmann N., Rajagopalan S., Berrada K., Yi T., Kinet J.P., Long E.O. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:1996;77.
41. Bléry M., Delon J., Trautmann A., Cambiaggi A., Olcese L., Biassoni R., Moretta L., Chavrier P., Moretta A., Daeron M., Vivier E. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs. J Biol Chem. 272:1997;8989.
42. Campbell K.S., Dessing M., Lopez-Botet M., Cella M., Colonna M. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J Exp Med. 184:1996;93.
43. Callewaert D.M., Lighbody J.J., Kaplan J., Joroszewski J., Peterson W.D., Rosenberg J.C. Cytotoxicity of human peripheral lymphocytes in cell-mediated lympholysis; antibody-dependent cell-mediated lympholysis and natural cytotoxicity assays after mixed lymphocyte culture. J Immunol. 121:1978;81.
44. Moretta A., Pantaleo G., Mingari M.C., Melioli G., Moretta L., Cerottini J.C. Assignment of human natural killer (NK)-like cells to the T cell lineage Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures . Eur J Immunol. 14:1984;121.
45. Mingari M.C., Moretta A., Moretta L. Regulation of KIR expression in human T cells a safety mechanism that may impair protective T-cell responses . Immunol Today. 19:1998;153.
46. Salazar-Mather T.P., Orange J.S., Biron C.A. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med. 187:1998;1.
47. Ikeda H., Lethé B., Lehmann F., Van Baren N., Baurain J.F., De Smet C., Chambost H., Vitale M., Moretta A., Boon T., Coulie P.G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 6:1997;199.
48. De Maria A., Ferraris A., Guastella M., Pilia S., Cantoni C., Polero L., Mingari M.C., Bassetti D., Fauci A.S., Moretta L. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes impairment of specific cytolytic functions . Proc Natl Acad Sci USA. 94:1997;10285.
49. Kagi D., Hengartner H. Different roles for cytotoxic T cells in the control of infections with cytopathic versus noncytopathic viruses. Curr Opin Immunol. 8:1996;472.
50. Mingari M.C., Vitale C., Cantoni C., Bellomo R., Ponte M., Schiavetti F., Bertone S., Moretta A., Moretta L. Interleukin-15-induced maturation of human natural killer cells from early thymic precursors selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor . Eur J Immunol. 27:1997;1374.
51. + T cells . Proc Natl Acad Sci USA. 95:1998;1172.
52. Brown M.G., Scalzo A.A., Matsumoto K., Yokoyama W.M. The natural killer gene complex a genetic basis for understanding natural killer cell function and innate immunity . Immunol Rev. 155:1997;53.
53. Bertone S., Schiavetti F., Bellomo R., Vitale C., Ponte M., Moretta L., Mingari M.C. Transforming growth factor-β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur J Immunol. 29:1999;23.
54. Tagaya Y., Bamford R.N., DeFilippis A.P., Waldmann T.A. IL-15 a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels . Immunity. 4:1996;329.
55. Meazza R., Gaggero A., Neglia F., Basso S., Sforzini S., Pereno R., Azzarone B., Ferrini S. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion role of different signal peptides . Eur J Immunol. 27:1997;1049.